Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Communication
  • Published:

Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations

European Journal of Clinical Nutrition volume 59, pages 480–488 (2005)Cite this article

Abstract

Background

Hyperhomocysteinemia (HHCY) is a risk factor for cardiovascular diseases (CVD). HHCY may interact with hypertension (HTEN) and an unfavorable cholesterol profile (UNFAVCHOL) to alter the risk of CVD.

Objectives

To estimate the prevalences of HHCY (1) isolated and (2) in combination with UNFAVCHOL and/or HTEN in different age categories. To provide information that may improve the screening and treatment of subjects at risk of CVD.

Design

Cross-sectional data on 12 541 men and 12 948 women aged 20+ y were used from nine European studies.

Results

The prevalence of isolated HHCY was 8.5% in subjects aged 20–40 y, 4.7% in subjects aged 40–60 y and 5.9% in subjects aged over 60 y. When combining all age groups, 5.3% had isolated HHCY and an additional 5.6% had HHCY in combination with HTEN and/or UNFAVCHOL. The combinations of risk factors increased with age and, except for HHCY&UNFAVCHOL, were more prevalent than predicted by chance. Of the young subjects (20–40 y), 24% suffered from one or more of the investigated CVD risk factors. This figure was 75.1% in the old subjects (60+ years).

Conclusions

A substantial number of subjects in selected European populations have HHCY (10.9%). In half of these cases, subjects suffer also from other CVD risk factors like UNFAVCHOL and HTEN. Older people in particular tend to have more than one risk factor. Healthcare professionals should be aware of this when screening and treating older people not only for the conventional CVD risk factors like UNFAVCHOL and HTEN but also HHCY, as this can easily be reduced through increased intake of folic acid via supplement or foods fortified with folic acid.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Alfthan G, Pekkanen J, Jauhiainen M, Pitkaniemi J, Karvonen M, Tuomilehto J, Salonen JT & Ehnholm C (1994): Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective finnish population based study. Atherosclerosis 106, 9–19.

    Article  CAS  Google Scholar 

  • Andersson A, Isaksson A & Hultberg B (1992): Homocysteine export from erythrocytes and its implication for plasma sampling. Clin. Chem. 38, 1311–1315.

    CAS  PubMed  Google Scholar 

  • Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH & Karanja N (1997): A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336, 1117–1124.

    Article  CAS  Google Scholar 

  • Araujo F, Lopes M, Goncalves L, Maciel MJ & Cunha-Ribeiro LM (2000): Hyperhomocysteinemia, MTHFR C677T genotype and low folate levels: a risk combination for acute coronary disease in a portuguese population [Letter]. Thromb. Haemost. 83, 517–518.

    Article  CAS  Google Scholar 

  • Arnesen E, Refsum H, Bonaa KH, Ueland PM, Forde OH & Nordrehaug JE (1995): Serum total homocysteine and coronary heart disease. Int. J. Epidemiol. 24, 704–709.

    Article  CAS  Google Scholar 

  • Ashfield-Watt PA, Whiting JM, Clark ZE, Moat SJ, Newcombe RG, Burr ML & McDowell IF (2003): A comparison of the effect of advice to eat either ‘5-a-day’ fruit and vegetables or folic acid-fortified foods on plasma folate and homocysteine. Eur. J. Clin. Nutr. 57, 316–323.

    Article  CAS  Google Scholar 

  • ATP III (2001): Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486–2497.

  • Bates CJ, Mansoor MA, vanderPols J, Prentice A, Cole TJ & Finch S (1997): Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur. J. Clin. Nutr. 51, 691–697.

    Article  CAS  Google Scholar 

  • Brattstrom L, Lindgren A, Israelsson B, Andersson A & Hultberg B (1994): Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J. Intern. Med. 236, 633–641.

    Article  CAS  Google Scholar 

  • Brouwer IA, Van Dusseldorp M, West CE, Meyboom S, Thomas CMG, Duran M, van het Hof KH, Eskes TKAB, Hautvast JGAJ, Steegers-Theunissen RPM, Hof KHV & Steegers Theunissen RPM (1999): Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in an dietary controlled trial. J. Nutr. 129, 1135–1139.

    Article  CAS  Google Scholar 

  • Clarke R & Armitage J (2000): Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin. Thromb. Hemost. 26, 341–348.

    Article  CAS  Google Scholar 

  • de Bree A, Verschuren WM & Blom HJ (2001a): Biological cardiovascular risk factors and plasma homocysteine levels in the general Dutch population. Atherosclerosis 154, 513–514.

    Article  CAS  Google Scholar 

  • de Bree A, Verschuren WMM, Blom HJ, De Graaf-Hess A, Trijbels FJM & Kromhout D (2001b): The homocysteine distribution: (mis)judging the burden. J. Clin. Epidemiol. 54, 462–469.

    Article  CAS  Google Scholar 

  • de Bree A, Verschuren WM, Kromhout D, mennen LI & Blom HJ (2002): Homocysteine and coronary heart disease: the importance of a distinction between low and high risk subjects. Int. J. Epidemiol. 31, 1268–1272.

    Article  Google Scholar 

  • de Lorgeril M, Salen P, Paillard F, Lacan P & Richard G (1999): Lipid-lowering drugs and homocysteine. Lancet 353, 209–210.

    Article  CAS  Google Scholar 

  • Dierkes J, Westphal S & Luley C (1999): Serum homocysteine increases after therapy with fenofibrate or bezafibrate. Lancet 354, 219–220.

    Article  CAS  Google Scholar 

  • Eliason SC, Ritter D, Chung HD & Creer M (1999): Interlaboratory variability for total homocysteine analysis in plasma. Clin. Chem. 45, 315–316.

    CAS  PubMed  Google Scholar 

  • European Atherosclerosis Society (1987): Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. Eur. Heart J. 8, 77–88.

  • Fokkema MR, Gilissen MF, van Doormaal JJ, Volmer M, Kema IP & Muskiet FA (2003): Fasting vs nonfasting plasma homocysteine concentrations for diagnosis of hyperhomocysteinemia. Clin. Chem. 49, 818–821.

    Article  CAS  Google Scholar 

  • Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, PalmaReis RJ, Boers GHJ, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, deValk HW, Luis ACS, ParrotRoulaud FM, Tan KS, Higgins I, Garcon D, Medrano MJ, Candito M, Evans A E & Andria G (1997): Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project. JAMA 277, 1775–1781.

    Article  CAS  Google Scholar 

  • Herrmann W, Quast S, Ullrich M, Schultze H, Bodis M & Geisel J (1999): Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 144, 91–101.

    Article  CAS  Google Scholar 

  • Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM & Stehouwer CD (2000): Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the hoorn study. Circulation 101, 1506–1511.

    Article  CAS  Google Scholar 

  • Hu FB, Manson JE & Willett WC (2001): Types of dietary fat and risk of coronary heart disease: a critical review. J. Am. Coll. Nutr. 20, 5–19.

    Article  Google Scholar 

  • Johansson L, Drevon CA & Aa Bjorneboe GE (1996): The Norwegian diet during the last hundred years in relation to coronary heart disease. Eur. J. Clin. Nutr. 50, 277–283.

    CAS  PubMed  Google Scholar 

  • Kjeldsen SE, Erdine S, Farsang C, Sleight P & Mancia G (2002): 1999 WHO/ISH Hypertension Guidelines—highlights & ESH Update. J. Hypertens. 20, 153–155.

    Article  CAS  Google Scholar 

  • Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ & Schouten EG (2002): MTHFR 677C → T polymorphism and risk of coronary heart disease: a meta- analysis. JAMA 288, 2023–2031.

    Article  CAS  Google Scholar 

  • Malinow MR, Axthelm MK, Meredith MJ, MacDonald NA & Upson BM (1994): Synthesis and transsulfuration of homocysteine in blood. J. Lab. Clin. Med. 123, 421–429.

    CAS  PubMed  Google Scholar 

  • Malinow MR, Bostom AG & Krauss RM (1999): Homocyst(e)Ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 99, 178–182.

    Article  CAS  Google Scholar 

  • Malinow MR, Ducimetiere P, Luc G, Evans AE, Arveiler D, Cambien F & Upson BM (1996): Plasma homocyst(e)Ine levels and graded risk for myocardial infarction: findings in two populations at contrasting risk for coronary heart disease. Atherosclerosis 126, 27–34.

    Article  CAS  Google Scholar 

  • mennen LI, de Courcy GP, Guilland JC, Ducros V, Bertrais S, Nicolas JP, Maurel M, Zarebska M, Favier A, Franchisseur C, Hercberg S & Galan P (2002): Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am. J. Clin. Nutr. 76, 1279–1289.

    Article  CAS  Google Scholar 

  • Moller J, Christensen L & Rasmussen K (1997): An external quality assessment study on the analysis of methylmalonic acid and total homocysteine in plasma. Scand. J. Clin. Lab. Invest. 57, 613–619.

    Article  CAS  Google Scholar 

  • Moller J, Rasmussen K & Christensen L (1999): External quality assessment of methylmalonic acid and total homocysteine. Clin. Chem. 45, 1536–1542.

    CAS  Google Scholar 

  • Netherlands Heart Foundation (2001): Homocysteine en hart- en vaatziekten [Homocysteine and cardiovascular disease]. The Hague: Netherlands Heart Foundation.

  • Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M & Kvale G (1995): Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274, 1526–1533.

    Article  CAS  Google Scholar 

  • Pfeiffer CM, Huff DL, Smith SJ, Miller DT & Gunter EW (1999): Comparison of plasma total homocysteine measurements in 14 laboratories: an international study. Clin. Chem. 45, 1261–1268.

    CAS  PubMed  Google Scholar 

  • Refsum H, Fiskerstrand T, Guttormsen A B & Ueland PM (1997): Assessment of homocysteine status. J. Inherit. Met. Dis. 20, 286–294.

    Article  CAS  Google Scholar 

  • Riddell LJ, Chisholm A, Williams S & Mann JI (2000): Dietary strategies for lowering homocysteine concentrations. Am. J. Clin. Nutr. 71, 1448–1454.

    Article  CAS  Google Scholar 

  • Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J & Weger M (2003): DACH-LIGA homocystein (German, Austrian and Swiss Homocysteine Society): Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin. Chem. Lab. Med. 41, 1392–1403.

    CAS  PubMed  Google Scholar 

  • Stehouwer CDA, Weijenberg MP, van den BM, Jakobs C, Feskens EJM & Kromhout D (1998): Serum homocysteine and risk of coronary heart disease and cerebrovascular disease in elderly men—a 10-year follow-up. Arteriol. Thromb. Vasc. Biol. 18, 1895–1901.

    Article  CAS  Google Scholar 

  • te Poele Pothoff MT, van den Berg M, Franken DG, Boers GH, Jakobs C, de Kroon IF, Eskes TK, Trijbels JM & Blom HJ (1995): Three different methods for the determination of total homocysteine in plasma. Ann. Clin. Biochem. 32, 218–220.

    Article  CAS  Google Scholar 

  • The Homocysteine Studies Collaboration (2002): Homocysteine and risk of ischemic heart disease and stroke: a meta- analysis. JAMA 288, 2015–2022.

    Article  Google Scholar 

  • Tripodi A, Chantarangkul V, Lombardi R, Lecchi A, Mannucci PM & Cattaneo M (2001): Multicenter study of homocysteine measurement—performance characteristics of different methods, influence of standards on interlaboratory agreement of results. Thromb. Haemost. 85, 291–295.

    Article  CAS  Google Scholar 

  • Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A & Allen RH (1993): Total homocysteine in plasma or serum: methods and clinical applications. Clin. Chem. 39, 1764–1779.

    CAS  PubMed  Google Scholar 

  • van Oort FV, Melse-Boonstra A, Brouwer IA, Clarke R, West CE, Katan MB & Verhoef P (2003): Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose–response study. Am. J. Clin. Nutr. 77, 1318–1323.

    Article  CAS  Google Scholar 

  • Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, Blackburn H, Buzina R, Dontas AS & Fidanza F (1995): Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274, 131–136.

    Article  CAS  Google Scholar 

  • Verschuren WMM, van Leer EM, Blokstra A, Seidell JC, Smit HA, Bueno de Mesquita HB, Obermann-de Boer GL & Kromhout D (1993): Cardiovascular disease risk factors in The Netherlands. Neth. J. Cardiol. 6, 205–210.

    Google Scholar 

  • Vollset SE, Refsum H, Tverdal A, Nygard O, Nordrehaug JE, Tell GS & Ueland PM (2001): Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordalans Homocysteine Study. Am. J. Clin. Nut. 74, 130–136.

    Article  CAS  Google Scholar 

  • Wald DS, Law M & Morris JK (2002): Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202.

    Article  Google Scholar 

  • Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR & Austin RC (2001): Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107, 1263–1273.

    Article  CAS  Google Scholar 

  • Westphal S, Dierkes J & Luley C (2001): Effects of fenofibrate and gemfibrozil on plasma homocysteine. Lancet 358, 39–40.

    Article  CAS  Google Scholar 

  • Working Group on Risk and High Blood Pressure (1985): An epidemiological approach to describing risk associated with blood pressure levels. Final Report of the Working Group on Risk and High Blood Pressure. Hypertension 7, 641–651.

Download references

Author information

Authors and Affiliations

  1. Unilever Health Institute, Unilever Research and Development Vlaardingen, The Netherlands

    A de Bree & N M J van der Put

  2. Scientific and Technical Institute of Nutrition and Food, UMR U557 INSERM/U1125 INRA, ISTNA-CNAM, Paris, France

    L I Mennen & P Galan

  3. Department of Chronic Disease Epidemiology, National Institute of Public Health and the Environment, Bilthoven, The Netherlands

    W M M Verschuren

  4. University Hospital St Radboud, Laboratory of Pediatrics and Neurology, University Hospital Nijmegen, The Netherlands

    H J Blom

  5. Elsie Widdowson Laboratory, MRC Human Nutrition Research, Cambridge, UK

    C J Bates

  6. Central Laboratory, Department of Clinical Chemistry, University of Saarland, Homburg/Saar, Germany

    W Herrmann & M Ullrich

  7. Medizinische Fakultät, Institut für Klinische Chemie und Pathobiochemie, Otto von Guericke Univesität, Magdeburg, Germany

    J Dierkes & S Westphal

  8. EMGO Institute, VU University Medical Centre, Amsterdam, The Netherlands

    L M Bouter, R J Heine, C D A Stehouwer, J M Dekker & G N Nijpels

  9. Department of Transfusion Medicine and Blood Bank, Molecular Biology Centre, Hospital S João, Porto, Portugal

    F Araújo & L M Cunha-Ribeiro

  10. Locus for Homocysteine and Related Vitamins, Armauer Hansen Hus, University of Bergen, Norway

    H Refsum, S Vollset, O Nygard & P M Ueland

Authors
  1. A de Bree
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N M J van der Put
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L I Mennen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W M M Verschuren
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H J Blom
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P Galan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C J Bates
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. W Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Ullrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J Dierkes
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. S Westphal
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. L M Bouter
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. R J Heine
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. C D A Stehouwer
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. J M Dekker
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. G N Nijpels
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. F Araújo
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. L M Cunha-Ribeiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. H Refsum
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. S Vollset
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. O Nygard
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. P M Ueland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A de Bree.

Additional information

Guarantor: A de Bree.

Contributors: AdB and NMJvdP were responsible for the study concept. AdB collected the data, performed the statistical analyses, and wrote the article. All contributors were responsible for critical revision of the manuscript and delivered important input for the content.

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Bree, A., van der Put, N., Mennen, L. et al. Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur J Clin Nutr 59, 480–488 (2005). https://doi.org/10.1038/sj.ejcn.1602097

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602097

Keywords

This article is cited by

Search

Advanced search

Quick links